SMT202400126T1 - Composizione per l’uso in un trattamento di anomalie delle cellule cervicali comprendente un composto di selenito e acido - Google Patents

Composizione per l’uso in un trattamento di anomalie delle cellule cervicali comprendente un composto di selenito e acido

Info

Publication number
SMT202400126T1
SMT202400126T1 SM20240126T SMT202400126T SMT202400126T1 SM T202400126 T1 SMT202400126 T1 SM T202400126T1 SM 20240126 T SM20240126 T SM 20240126T SM T202400126 T SMT202400126 T SM T202400126T SM T202400126 T1 SMT202400126 T1 SM T202400126T1
Authority
SM
San Marino
Prior art keywords
acid
treatment
composition
cervical cell
cell abnormalities
Prior art date
Application number
SM20240126T
Other languages
English (en)
Italian (it)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of SMT202400126T1 publication Critical patent/SMT202400126T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SM20240126T 2020-03-03 2021-03-03 Composizione per l’uso in un trattamento di anomalie delle cellule cervicali comprendente un composto di selenito e acido SMT202400126T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
PCT/EP2021/055230 WO2021175877A1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
EP21709400.2A EP4084788B1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (1)

Publication Number Publication Date
SMT202400126T1 true SMT202400126T1 (it) 2024-05-14

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20240126T SMT202400126T1 (it) 2020-03-03 2021-03-03 Composizione per l’uso in un trattamento di anomalie delle cellule cervicali comprendente un composto di selenito e acido

Country Status (23)

Country Link
US (1) US20230092142A1 (cg-RX-API-DMAC7.html)
EP (2) EP3875083A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840859B2 (cg-RX-API-DMAC7.html)
CN (1) CN115279358A (cg-RX-API-DMAC7.html)
AR (1) AR122387A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021231205B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022017436A2 (cg-RX-API-DMAC7.html)
CL (1) CL2022002363A1 (cg-RX-API-DMAC7.html)
CY (1) CY1126764T1 (cg-RX-API-DMAC7.html)
ES (1) ES2976058T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240374T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066384T2 (cg-RX-API-DMAC7.html)
IL (1) IL296146A (cg-RX-API-DMAC7.html)
MA (1) MA58262B1 (cg-RX-API-DMAC7.html)
MD (1) MD4084788T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022010838A (cg-RX-API-DMAC7.html)
PL (1) PL4084788T3 (cg-RX-API-DMAC7.html)
RS (1) RS65349B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400126T1 (cg-RX-API-DMAC7.html)
TW (1) TW202146004A (cg-RX-API-DMAC7.html)
UA (1) UA130108C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021175877A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202208848B (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Also Published As

Publication number Publication date
JP2023516153A (ja) 2023-04-18
EP3875083A1 (en) 2021-09-08
MD4084788T2 (ro) 2024-06-30
BR112022017436A2 (pt) 2022-10-18
HUE066384T2 (hu) 2024-07-28
PL4084788T3 (pl) 2024-06-03
UA130108C2 (uk) 2025-11-12
EP4084788B1 (en) 2024-02-14
CL2022002363A1 (es) 2023-03-31
ZA202208848B (en) 2024-09-25
ES2976058T3 (es) 2024-07-22
AU2021231205A1 (en) 2022-09-01
MX2022010838A (es) 2022-09-27
CY1126764T1 (el) 2026-02-25
MA58262B1 (fr) 2024-03-29
WO2021175877A1 (en) 2021-09-10
CN115279358A (zh) 2022-11-01
RS65349B1 (sr) 2024-04-30
AR122387A1 (es) 2022-09-07
EP4084788A1 (en) 2022-11-09
HRP20240374T1 (hr) 2024-06-07
JP7840859B2 (ja) 2026-04-06
AU2021231205B2 (en) 2026-02-26
TW202146004A (zh) 2021-12-16
EP4084788C0 (en) 2024-02-14
CA3167015A1 (en) 2021-09-10
US20230092142A1 (en) 2023-03-23
IL296146A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
IL204860A (en) Use of placenta containing mid-cd56 + natural killer cells for drug production
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
HUE070031T2 (hu) Új savszekréciós inhibitor és alkalmazása
EP2132225A4 (en) COMBINED USE OF NANOG AND OCT4 PERMEABLE TO CELLS TO INCREASE SELF-RENEWAL AND DELETE DIFFERENTIATION OF STEM CELLS
IL316882A (en) Piperidinyl-methyl-purine amine D-tartaric acid salts, crystalline forms, and their use in the treatment of diseases and medical conditions
HUE066384T2 (hu) Szelenitet és savat tartalmazó gyógyszerkészítmény méhnyaksejt rendellenességeinek kezelésére
EP4346793A4 (en) AMINO ACID HYDRATION FORMULATION AND METHOD OF USE
GB202207581D0 (en) Improvements in and relating to nitrification inhibitors
ES3066377T3 (en) (2s)-2-aminopentanethioic acid for use as medicament and in therapy of amyotrophic lateral sclerosis
IL327395A (en) Use of ALVELESTAT in specific patients
HUE067238T2 (hu) TEMPO-származékok oldata elektrolitként történõ alkalmazásra redox folyadékáramos cellákban
CA215160S (en) Ready to use plant treatment agent applicator
HUE066689T2 (hu) TEMPO-származékok oldata elektrolitként történõ alkalmazásra redox folyadékáramos cellákban
IL314205A (en) Ramibrutinib for use in the treatment of hidradenitis suppurativa
WO2009003463A3 (de) Verwendung von deuteriumoxid zur behandlung von virus-basierten erkrankungen der haut
EA201000338A1 (ru) Применение гестагенов в комбинации с (6s)-5-метилтетрагидрофолатом для терапии эндометриоза с одновременным снижением побочных эффектов терапии и снижением риска врожденных патологий в начале беременности
IL326722A (en) Quinones for use in the treatment of red blood cell enzymopathies
IL325337A (en) Using hair stem cells in wound healing
GB202318596D0 (en) Compounds for use in treatment and prophylaxis
UA51463U (ru) Способ комплексного лечения больных онихомикозами
IL317808A (en) Use of (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in cancer treatment
CA3264062A1 (en) VETERINARY COMPOSITIONS INTENDED FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
CA3301596A1 (en) Quinones for use in the treatment of red blood cell enzymopathies
CA3301600A1 (en) Quinones for use in the treatment of red blood cell enzymopathies
GB202215142D0 (en) Novel cell lines and their use in therapy